NCT06801392Recruiting
Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients
The Acute Efficacy and Safety of Left Atrial Posterior Wall and Mitral Isthmus Ablation in Patients With Non-Paroxysmal Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 21 Nov 2025
Brief summary (registry, in English)
An observational study evaluating efficacy and safety of the Varipulse catheter in pulsed-field ablation of atrial fibrillation
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 10 Jan 2025
- Start date
- 1 Jan 2025
- Primary completion date
- Dec 2025
- Lead sponsor
- Charles University, Czech Republic
- Diseases
- Atrial fibrillation
- NCT number
- NCT06801392
What you commit to
- Study type: Observational
- Planned participants: 50
- From 1 Jan 2025 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous left atrial ablation (either using pulsed-field or radiofrequency energy)
Other illness
- hematological disorders that can be associated with spontaneous hemolysis
- chronic kidney disease stage 3 or worse
Who the study is looking for
- non-paroxysmal atrial fibrillation
- an indication for catheter ablation according current guidelines
- willingness to sign informed content.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Kralovske Vinohrady Coordinator of this site? Confirm its status | Prague | Czechia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.